KaloCyte, Inc. — Form D
KaloCyte, Inc. of ST. LOUIS, MO, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-08. The offering totals $800K, of which $800K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-05-08
- Form: D
- Accession: 0001738542-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $800K
- Amount sold: $800K
- Minimum investment: $10K
- Investors: 3
- Date of first sale: 2018-04-27
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-311892
Issuer
- Name: KaloCyte, Inc.
- CIK: 0001738542
- Entity type: Corporation
- Jurisdiction: MISSOURI
- Incorporated: 2016
- Address: 4320 FOREST PARK, ST. LOUIS, MO, 63108
- Phone: 3148099819
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Allan Doctor | Director | Saint Louis, MO |
| Daniel Getman | Director | Kirksville, MO |
| Gregory Lanza | Director | Saint Louis, MO |
| Dipanjan Pan | Director | State College, PA |
| Philip Spinella | Director | Chesterfield, MO |
| Allan Doctor | Executive Officer | Saint Louis, MO |
More